Verastem Oncology
VSTM
#6412
Rank
C$1.07 B
Marketcap
C$14.31
Share price
-2.26%
Change (1 day)
94.43%
Change (1 year)

Revenue for Verastem Oncology (VSTM)

Revenue in 2025 (TTM): C$18.56 Million

According to Verastem Oncology 's latest financial reports the company's current revenue (TTM ) is C$18.48 Million. In 2024 the company made a revenue of C$14.34 Million an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verastem Oncology from 2011 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$18.56 M29.34%
2024 C$14.34 M
2023 N/A-100%
2022 C$3.52 M34.64%
2021 C$2.61 M-97.68%
2020 C$0.11 B395.08%
2019 C$22.79 M-37.36%
2018 C$36.39 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Curis
CRIS
C$16.09 M-12.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$86.73 B 469,187.69%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$19.01 B 102,787.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$58.51 B 316,461.61%๐Ÿ‡ฌ๐Ÿ‡ง UK